Analystreport

Avadel Pharmaceuticals PLC (NASDAQ: AVDL) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $18.00 price target on the stock, up previously from $14.00...

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com